Marc Rubin, Director at GALECTIN THERAPEUTICS INC (GALT), sold 58,100 shares at $6.08 ($353K) on 2018-08-30, disclosed to the SEC on 2018-09-04.
Open-market sale of $353k GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TTNP | BUY | 2018-09-25 | $100K | — | Filing → |
| GALT | SELL | 2018-09-06 | $78K | — | Filing → |
| GALT | BUY | 2017-12-08 | $13K | — | Filing → |